LLY

940.2

-0.58%↓

JNJ

186.13

+0.02%↑

UNH

324.98

-0.51%↓

NVS

126.13

+0.88%↑

ABT

124.15

-0.1%↓

LLY

940.2

-0.58%↓

JNJ

186.13

+0.02%↑

UNH

324.98

-0.51%↓

NVS

126.13

+0.88%↑

ABT

124.15

-0.1%↓

LLY

940.2

-0.58%↓

JNJ

186.13

+0.02%↑

UNH

324.98

-0.51%↓

NVS

126.13

+0.88%↑

ABT

124.15

-0.1%↓

LLY

940.2

-0.58%↓

JNJ

186.13

+0.02%↑

UNH

324.98

-0.51%↓

NVS

126.13

+0.88%↑

ABT

124.15

-0.1%↓

LLY

940.2

-0.58%↓

JNJ

186.13

+0.02%↑

UNH

324.98

-0.51%↓

NVS

126.13

+0.88%↑

ABT

124.15

-0.1%↓

Search

Pliant Therapeutics Inc

Отворен

1.59 -6.47

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.6

Максимум

1.69

Ключови измерители

By Trading Economics

Приходи

13M

-43M

Марж на печалбата

-2,190.837

Служители

171

EBITDA

17M

-42M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+66.46% upside

Дивиденти

By Dow Jones

Следващи печалби

6.11.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.8M

103M

Предишно отваряне

8.06

Предишно затваряне

1.59

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

Pliant Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.11.2025 г., 23:51 ч. UTC

Печалби

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5.11.2025 г., 23:10 ч. UTC

Печалби

DBS Third Quarter Net Dips 2.0%

5.11.2025 г., 22:55 ч. UTC

Печалби

Arm Holdings 2Q Profit Climbs on Record Demand

5.11.2025 г., 22:23 ч. UTC

Печалби

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5.11.2025 г., 23:52 ч. UTC

Печалби

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5.11.2025 г., 23:49 ч. UTC

Печалби

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5.11.2025 г., 23:49 ч. UTC

Печалби

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5.11.2025 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5.11.2025 г., 23:42 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5.11.2025 г., 23:12 ч. UTC

Печалби

Nutrien 3Q Adj EPS 97c >NTR.T

5.11.2025 г., 23:11 ч. UTC

Печалби

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5.11.2025 г., 23:10 ч. UTC

Печалби

Nutrien 3Q Sales $6.01B >NTR.T

5.11.2025 г., 23:10 ч. UTC

Пазарно говорене
Печалби

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5.11.2025 г., 23:10 ч. UTC

Печалби

Nutrien 3Q EPS 96c >NTR.T

5.11.2025 г., 23:04 ч. UTC

Печалби

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5.11.2025 г., 23:03 ч. UTC

Пазарно говорене

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5.11.2025 г., 22:55 ч. UTC

Пазарно говорене

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5.11.2025 г., 22:55 ч. UTC

Печалби

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5.11.2025 г., 22:51 ч. UTC

Печалби

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5.11.2025 г., 22:50 ч. UTC

Печалби

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5.11.2025 г., 22:44 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5.11.2025 г., 22:43 ч. UTC

Пазарно говорене
Печалби

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5.11.2025 г., 22:36 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

5.11.2025 г., 22:36 ч. UTC

Пазарно говорене

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5.11.2025 г., 22:20 ч. UTC

Пазарно говорене

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5.11.2025 г., 22:12 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5.11.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5.11.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Responds to Delaware Chancery Court Ruling

5.11.2025 г., 22:01 ч. UTC

Печалби

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5.11.2025 г., 22:01 ч. UTC

Печалби

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Сравнение с други в отрасъла

Ценова промяна

Pliant Therapeutics Inc Прогноза

Ценова цел

By TipRanks

66.46% нагоре

12-месечна прогноза

Среден 2.68 USD  66.46%

Висок 4 USD

Нисък 1.7 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Pliant Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

7 ratings

1

Купи

5

Задържане

1

Продай

Техническа оценка

By Trading Central

1.43 / 1.6Подкрепа & съпротива

Краткосрочен план

Very Strong Bearish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
help-icon Live chat